Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TELA Bio (TELA) Gross Margin (2018 - 2025)

TELA Bio (TELA) has 8 years of Gross Margin data on record, last reported at 67.52% in Q3 2025.

  • For Q3 2025, Gross Margin fell 31.0% year-over-year to 67.52%; the TTM value through Sep 2025 reached 67.23%, down 107.0%, while the annual FY2024 figure was 67.08%, 154.0% down from the prior year.
  • Gross Margin reached 67.52% in Q3 2025 per TELA's latest filing, down from 69.84% in the prior quarter.
  • Across five years, Gross Margin topped out at 70.38% in Q2 2023 and bottomed at 58.96% in Q1 2021.
  • Average Gross Margin over 5 years is 66.37%, with a median of 67.56% recorded in 2025.
  • Peak YoY movement for Gross Margin: surged 785bps in 2021, then tumbled -481bps in 2024.
  • A 5-year view of Gross Margin shows it stood at 67.58% in 2021, then rose by 4bps to 70.35% in 2022, then decreased by -3bps to 68.38% in 2023, then dropped by -7bps to 63.58% in 2024, then increased by 6bps to 67.52% in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 67.52% in Q3 2025, 69.84% in Q2 2025, and 67.56% in Q1 2025.